Hydrolytic Degradation of Poly DL-(Lactide)
Poly (DL-lactide) or poly (DL-lactic acid) (PLA), has been proposed as a component of several controlled-release drug forms because it degrades in living tissue to harmless products (1,2). Thus, devices or particles made of this material could be slowly metabolized and thus leave the body harmlessly after the drug is released. The solubility of PLA in many organic solvents (ketones, esters, aromatics, and chlorinated aliphatics) gives considerable flexibility in device fabrication. PLA has been proposed for use as fibers (3), microcapsules (4), and larger implants (2). Experimenters have made a variety of drug forms and devices to deliver drugs ranging from birth-control agents and narcotic antagonists, to anticoagulants and depressants.
KeywordsIntrinsic Viscosity Hydrolytic Degradation Cyclic Dimer Narcotic Antagonist Large Implant
Unable to display preview. Download preview PDF.
- 1.A. G. Boswell and R. E. Scribner, U.S. Patent 3,773, 919 (1973)Google Scholar
- 3.R. J. Ruderman et al, Trans. A.S.A.I.O., XVIII 30 (1972)Google Scholar
- 4.L. R. Beck et al, Fertil. Steril., 31, 545 (1979)Google Scholar
- 5.C. Thies in “Microencapsulation”, T. Kondo ed., Techno, Inc., Tokyo (1979), p. 426Google Scholar
- 7.C. A. Bischoff, Chem. Ber., 26, 263 (1903)Google Scholar
- 9.A. K. Schneider, U.S. Patent 2,703, 316 (1955)Google Scholar
- 10.C. H. Holten et al, “Lactic Acid”, Verlag Chemie Weinheim, (1971), p. 232Google Scholar
- 13.A. Schindler et al, “Biodegradable Polymers for Sustained Drug Delivery, Continuing Topics in Polymer Sci.”, Vol. II, Plenum 1977Google Scholar
- 15.A. Seidel, “Solubilities of Organic Compounds” 3rd ed., D. Van Nostrand Co., Inc., New York (1941)Google Scholar